Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies

Adiponectin, a protein exclusively secreted by adipose tissue but present at low levels in obesity, is now widely recognised as a key determinant of insulin sensitivity and of protection against obesity-associated metabolic syndrome. In this review we explain how genetic findings have contributed to a better understanding of the physiological role of adiponectin in humans. The adiponectin-encoding gene, ADIPOQ (ACDC), is very polymorphic: many frequent exonic synonymous, intronic and promoter single-nucleotide polymorphisms (SNPs) have been identified, as well as a few rare exonic amino acid substitutions. Several of these variations additively contribute to the modulation of adiponectin level and function, and associate with insulin sensitivity, type 2 diabetes and vascular complications of obesity.

[1]  I. Wittmann.  Insulin Resistance and Metabolic Syndrome , 2007, EJIFCC.

[2]  Lisa J. Martin,et al.  Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. , 2006, Diabetes.

[3]  F. Kronenberg,et al.  Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. , 2006, Diabetes.

[4]  Béatrice Jouret,et al.  ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. , 2006, Diabetes.

[5]  W. Garvey,et al.  Adiponectin multimeric complexes and the metabolic syndrome trait cluster. , 2006, Diabetes.

[6]  P. J. Larsen,et al.  ACDC/Adiponectin and PPAR‐γ Gene Polymorphisms: Implications for Features of Obesity , 2005 .

[7]  Takashi Kadowaki,et al.  Combination , 2019, Understanding the Law of Assignment.

[8]  F. Schick,et al.  Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat , 2005, Diabetologia.

[9]  M. Matsuda,et al.  [Hypoadiponectinemia implies the development of atherosclerosis in carotid and coronary arteries]. , 2005, Journal of cardiology.

[10]  W. Garvey,et al.  Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200 , 2005, Journal of Lipid Research.

[11]  L. Landsberg.  Insulin resistance and the metabolic syndrome , 2005, Diabetologia.

[12]  M. Tarnopolsky,et al.  Regulating adiponectin: of flax and flux , 2005, Diabetologia.

[13]  M. Arca,et al.  The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years) , 2005, Journal of Molecular Medicine.

[14]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[15]  E. Rimm,et al.  The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. , 2005, Diabetes.

[16]  Donald W. Bowden,et al.  Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study , 2005, Human Genetics.

[17]  K. Clément,et al.  Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity , 2005, Diabetologia.

[18]  C. Bouchard,et al.  Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study , 2005, Annals of medicine.

[19]  M. Laakso,et al.  The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. , 2005, Diabetes.

[20]  P. Scherer,et al.  Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome , 2005, Journal of internal medicine.

[21]  D. Savage.  PPARγ as a metabolic regulator: insights from genomics and pharmacology , 2005, Expert Reviews in Molecular Medicine.

[22]  P. J. Larsen,et al.  ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. , 2005, Obesity research.

[23]  Philippe Froguel,et al.  Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians. , 2005, Diabetes.

[24]  J. Nishioka,et al.  Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects. , 2005, International journal of molecular medicine.

[25]  J. O’Connell,et al.  Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. , 2005, Diabetes.

[26]  W. Sheu,et al.  Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese origin. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  P. Froguel,et al.  Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. , 2004, Diabetes.

[28]  David Couper,et al.  Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2004, Diabetes.

[29]  A. Doria,et al.  The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. , 2004, Diabetes care.

[30]  K. Choi,et al.  Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans , 2004, Clinical endocrinology.

[31]  C. Dina,et al.  The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non‐insulin‐dependent) diabetes mellitus , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[32]  T. Ogihara,et al.  Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[33]  S. Hadjadj,et al.  Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. , 2004, Diabetes.

[34]  K. Humphreys,et al.  Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. , 2004, Diabetes.

[35]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  S. Haffner,et al.  Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. , 2003, Diabetes care.

[37]  B. Zinman,et al.  Adiponectin in a native Canadian population experiencing rapid epidemiological transition. , 2003, Diabetes care.

[38]  P. Froguel,et al.  Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.

[39]  T. Funahashi,et al.  Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. , 2003, Diabetes.

[40]  B. Nicklas,et al.  Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. , 2003, Diabetes care.

[41]  Claude Bouchard,et al.  Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. , 2003, Metabolism: clinical and experimental.

[42]  M. Igarashi,et al.  Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. , 2003, Diabetes care.

[43]  T. Quertermous,et al.  Genetic epistasis of adiponectin and PPARγ2 genotypes in modulation of insulin sensitivity: a family-based association study , 2003, Diabetologia.

[44]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[45]  Lee-Ming Chuang,et al.  Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity , 2003, Journal of Molecular Medicine.

[46]  P. Froguel,et al.  The genetics of adiponectin , 2003, Current diabetes reports.

[47]  C. Dina,et al.  Does the −11377 promoter variant of APM1 gene contribute to the genetic risk for Type 2 diabetes mellitus in Japanese families? , 2003, Diabetologia.

[48]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[49]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[50]  K. Clément,et al.  Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. , 2002, Human molecular genetics.

[51]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[52]  M. Matsuda,et al.  Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.

[53]  P. Scherer,et al.  A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. , 2002, Diabetes.

[54]  K. Clément,et al.  Positional candidate gene analysis of Lim domain homeobox gene (Isl-1) on chromosome 5q11-q13 in a French morbidly obese population suggests indication for association with type 2 diabetes. , 2002, Diabetes.

[55]  C. Dina,et al.  Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. , 2002, Diabetes.

[56]  M. Stumvoll,et al.  Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. , 2002, Diabetes.

[57]  J. Blangero,et al.  The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[58]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[59]  E. Lander,et al.  On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.

[60]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[61]  J. Pritchard.  Are rare variants responsible for susceptibility to complex diseases? , 2001, American journal of human genetics.

[62]  T. Funahashi,et al.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.

[63]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[64]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Schölmerich,et al.  Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[66]  J. Weber,et al.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Dina,et al.  Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.

[68]  P. Froguel,et al.  An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort , 2000, Diabetologia.

[69]  S. Kihara,et al.  Genomic structure and mutations in adipose-specific gene, adiponectin , 2000, International Journal of Obesity.

[70]  T Nakamura,et al.  An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[71]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[72]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[73]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[74]  P. O'Connell,et al.  Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. , 1999, American journal of human genetics.

[75]  N. Shimizu,et al.  Organization of the gene for gelatin-binding protein (GBP28). , 1999, Gene.

[76]  K. Clément,et al.  A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10 , 1998, Nature Genetics.

[77]  M. Permutt,et al.  Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR ): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians , 1998, Diabetologia.

[78]  M. Ehm,et al.  An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. , 1998, The Journal of clinical investigation.

[79]  Y. Nakano,et al.  Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.

[80]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[81]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[82]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[83]  A. S. Macdonald,et al.  Structural changes in the subcutaneous compartment in morbid obesity. , 1993, Obesity research.

[84]  E. Ravussin,et al.  Insulin resistance associated with lower rates of weight gain in Pima Indians. , 1991, The Journal of clinical investigation.

[85]  J H Ruijs,et al.  Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. , 1988, European journal of clinical nutrition.

[86]  Frank Russell,et al.  The Pima Indians , 1975 .